Literature DB >> 23535930

Antibody-drug conjugates.

Rachel S Zolot, Satarupa Basu, Ryan P Million.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23535930     DOI: 10.1038/nrd3980

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Antibody-drug conjugates for cancer: poised to deliver?

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

  1 in total
  47 in total

1.  Design, Synthesis and Application of Fluorine-Labeled Taxoids as 19F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems.

Authors:  Joshua D Seitz; Jacob G Vineberg; Longfei Wei; Jonathan F Khan; Brendan Lichtenthal; Chi-Feng Lin; Iwao Ojima
Journal:  J Fluor Chem       Date:  2015-03-01       Impact factor: 2.050

2.  Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design.

Authors:  Katie F Maass; Chethana Kulkarni; Alison M Betts; K Dane Wittrup
Journal:  AAPS J       Date:  2016-02-24       Impact factor: 4.009

Review 3.  Building better monoclonal antibody-based therapeutics.

Authors:  George J Weiner
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

Review 4.  Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection.

Authors:  S Sadekar; I Figueroa; M Tabrizi
Journal:  AAPS J       Date:  2015-05-02       Impact factor: 4.009

5.  A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs.

Authors:  Andrea E Prota; Katja Bargsten; J Fernando Diaz; May Marsh; Carmen Cuevas; Marc Liniger; Christian Neuhaus; Jose M Andreu; Karl-Heinz Altmann; Michel O Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

6.  Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted azide-alkyne cycloadditions.

Authors:  Xiuru Li; Tao Fang; Geert-Jan Boons
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-23       Impact factor: 15.336

7.  Strategic Incorporation of Fluorine into Taxoid Anticancer Agents for Medicinal Chemistry and Chemical Biology Studies.

Authors:  Iwao Ojima
Journal:  J Fluor Chem       Date:  2017-01-03       Impact factor: 2.050

Review 8.  Challenges and new frontiers in analytical characterization of antibody-drug conjugates.

Authors:  Anil Wagh; Hangtian Song; Ming Zeng; Li Tao; Tapan K Das
Journal:  MAbs       Date:  2018-01-05       Impact factor: 5.857

9.  Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin.

Authors:  Alison M Betts; Nahor Haddish-Berhane; John Tolsma; Paul Jasper; Lindsay E King; Yongliang Sun; Subramanyam Chakrapani; Boris Shor; Joseph Boni; Theodore R Johnson
Journal:  AAPS J       Date:  2016-05-19       Impact factor: 4.009

Review 10.  HDX-MS guided drug discovery: small molecules and biopharmaceuticals.

Authors:  David P Marciano; Venkatasubramanian Dharmarajan; Patrick R Griffin
Journal:  Curr Opin Struct Biol       Date:  2014-08-30       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.